Gene · 3735
Papers1,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Enigmatic Genetic Landscape of Hereditary Hearing Loss: A Multistep Diagnostic Strategy in the Italian Population. | Biomedicines | 2023 | 36979683 | PubTator, text mining | PubMed |
Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis. | Curr Oncol | 2023 | 36975441 | PubTator, text mining | PubMed |
| The effects of physical activity on glutamate neurotransmission in neuropsychiatric disorders. | Front Sports Act Living | 2023 | 36949894 | PubTator, text mining | PubMed |
| N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer. | Front Genet | 2023 | 36936424 | PubTator, text mining | PubMed |
| Identification of a Novel Idiopathic Epilepsy Risk Locus and a Variant in the CCDC85A Gene in the Dutch Partridge Dog. | Animals (Basel) | 2023 | 36899667 | PubTator, text mining | PubMed |
| HIV-1 Gag Binds the Multi-Aminoacyl-tRNA Synthetase Complex via the EPRS Subunit. | Viruses | 2023 | 36851687 | PubTator, text mining | PubMed |
| Case report: A novel homozygous histidine triad nucleotide-binding protein 1 mutation featuring distal hereditary motor-predominant neuropathy with rimmed vacuoles. | Front Neurol | 2023 | 36846110 | PubTator, text mining | PubMed |
| Differentially Expressed Genes and Molecular Susceptibility to Human Age-Related Diseases. | Int J Mol Sci | 2023 | 36835409 | PubTator, text mining | PubMed |
| MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation. | Int J Mol Sci | 2023 | 36834926 | PubTator, text mining | PubMed |
| Towards a Cure for HARS Disease. | Genes (Basel) | 2023 | 36833180 | PubTator, text mining | PubMed |
| Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer. | Cell Death Discov | 2023 | 36813783 | PubTator, text mining | PubMed |
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. | Proteomes | 2023 | 36810562 | PubTator, text mining | PubMed |
| Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone. | Front Oncol | 2023 | 36776323 | PubTator, text mining | PubMed |
| NMDA Receptor and Its Emerging Role in Cancer. | Int J Mol Sci | 2023 | 36768862 | PubTator, text mining | PubMed |
| Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer. | Front Immunol | 2023 | 36761724 | PubTator, text mining | PubMed |
| Urinary protein biomarkers based on LC-MS/MS analysis to discriminate vascular dementia from Alzheimer's disease in Han Chinese population. | Front Aging Neurosci | 2023 | 36761180 | PubTator, text mining | PubMed |
| A mechanistic evaluation of human beta defensin 2 mediated protection of human skin barrier in vitro. | Sci Rep | 2023 | 36755116 | PubTator, text mining | PubMed |
| The tRNA identity landscape for aminoacylation and beyond. | Nucleic Acids Res | 2023 | 36744444 | PubTator, text mining | PubMed |
| Identification of immune signatures in Parkinson's disease based on co-expression networks. | Front Genet | 2023 | 36733342 | PubTator, text mining | PubMed |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. | Mol Cancer | 2023 | 36717905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3735/papers?page=9